FDA authorizes Moderna booster shots for release from Catalent facility
The US regulator has given the green light for the distribution of doses of Moderna's COVID-19 booster shots from a manufacturing plant in Indiana run by Catalent.
Archives for September 22, 2022
Solving CAR-T’s viral vector problem: Cellares and iVexSol team up to streamline manufacturing
San Francisco based Cellares is partnering with Lexington, Massachusetts headquartered iVexSol to accelerate and improve the quality of viral vector manufacturing and transduction.
‘Data like these give us energy and hope’: Biogen highlights tofersen potential in motor-neuron disease with NEJM study
An extension of a Phase 3 trial for Biogen’s tofersen shows benefits in a form of motor neuron disease, according to a study published in the New England Journal of Medicine (NEJM) this week.
AmerisourceBergen inks €1.3bn PharmaLex buyout to grow biopharma service business
AmerisourceBergen has followed through on plans to grow its biopharma services business by striking a €1.28bn ($1.28bn) deal to acquire PharmaLex.
The Center for Breakthrough Medicines signs deal to manufacture jCyte’s retinal degenerative disease cell therapy
The Center for Breakthrough Medicines, a Philadelphia cell and gene therapy CDMO, will become the primary manufacturer of jCyte’s jCell cell therapy.